The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Animal models of drug-induced liver injury
Abstract
Drug-induced liver injury (DILI) presents unique challenges for consumers, clinicians, and regulators. It is the most common cause of acute liver failure in the US. It is also one of the most common reasons for termination of new drugs during pre-clinical testing and withdrawal of new drugs post-marketing. DILI is generally divided into two forms: intrinsic and idiosyncratic. Many of the challenges with DILI are due in large part to poor understanding of the mechanisms of toxicity. Although useful models of intrinsic DILI are available, they are frequently misused. Modeling idiosyncratic DILI presents greater challenges, but promising new models have recently been developed. The purpose of this manuscript is to provide a critical review of the most popular animal models of DILI, and to discuss the future of DILI research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other medications/herbals/nutrients including aspirin, amiodarone, chemotherapeutic agents, paraquat, carbon tetrachloride, and mushroom poisons can also lead to DILI.[9]”
From Drug-induced liver injury: Diagnosis, management and the role of liver transplantation (2025) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sterile inflammation in the liver
Kubes, P., & Mehal, W. Z. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.09.008 · Cited by 666
Tsuchida, T., Lee, Y. A., Fujiwara, N., Ybanez, M., Allen, B., Martins, S., Fiel, M. I., Goossens, N., Chou, H.-I., Hoshida, Y., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.011 · Cited by 583
Hanawa, N., Shinohara, M., Saberi, B., Gaarde, W. A., Han, D., & Kaplowitz, N. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708916200 · Cited by 527
Knight, T. R. (2001) · Toxicological Sciences · doi:10.1093/toxsci/62.2.212 · Cited by 313
Central role of mitochondria in drug-induced liver injury
Pessayre, D., Fromenty, B., Berson, A., Robin, M.-A., Lettéron, P., Moreau, R., & Mansouri, A. (2012) · Drug Metabolism Reviews · doi:10.3109/03602532.2011.604086 · Cited by 277
Chakraborty, M., Fullerton, A. M., Semple, K., Chea, L. S., Proctor, W. R., Bourdi, M., Kleiner, D. E., Zeng, X., Ryan, P. M., Dagur, P. K., et al. (2015) · Hepatology · doi:10.1002/hep.27764 · Cited by 64
Research works printed but not linked: 127
- Lee, 2008, Etiologies of acute liver failure, Semin. Liver Dis., 28, 142, 10.1055/s-2008-1073114 · DOI · Paper page
- Davern, 2006, Measurement of serum acetaminophen-protein adducts in patients with acute liver failure, Gastroenterology, 130, 687, 10.1053/j.gastro.2006.01.033 · DOI · Paper page
- Ganger, 2018, Acute liver failure study group. Acute liver failure of indeterminate etiology: a comprehensive systematic approach by an expert committee to establish causality, Am. J. Gastroenterol., 10.1038/s41395-018-0160-2 · DOI
- James, 2006, Pediatric acute liver failure study group. Detection of acetaminophen protein adducts in children with acute liver failure of indeterminate cause, Pediatrics, 118, e676, 10.1542/peds.2006-0069 · DOI
- Issa, 2007, Drug withdrawals in the United States: a systematic review of the evidence and analysis of trends, Curr. Drug Saf., 2, 177, 10.2174/157488607781668855 · DOI
- Onakpoya, 2016, Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature, BMC Med., 14
- Solotke, 2018, New and incremental FDA black box warnings from 2008 to 2015, Expert Opin. Drug Saf., 17, 117, 10.1080/14740338.2018.1415323 · DOI
- Lammert, 2008, Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals, Hepatology, 47, 2003, 10.1002/hep.22272 · DOI · Paper page
- Uetrecht, 2001, Prediction of a new drug's potential to cause idiosyncratic reactions, Curr. Opin. Drug Discov. Devel., 4, 55
- Walgren, 2005, Role of metabolism in drug-induced idiosyncratic hepatotoxicity, Crit. Rev. Toxicol., 35, 325, 10.1080/10408440590935620 · DOI · Paper page
- de Morais, 1992, Decreased glucuronidation and increased bioactivation of acetaminophen in Gilbert's syndrome, Gastroenterology, 102, 577, 10.1016/0016-5085(92)90106-9 · DOI · Paper page
- Rubin, 2018, Acetaminophen-induced acute liver failure is more common and more severe in women, Clin. Gastroenterol. Hepatol., 16, 936, 10.1016/j.cgh.2017.11.042 · DOI
- Watkins, 2006, Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily, JAMA, 296, 87, 10.1001/jama.296.1.87 · DOI · Paper page
- Mak, 2018, Editor's highlight: an impaired immune tolerance animal model distinguishes the potential of troglitazone/pioglitazone and tolcapone/entacapone to cause IDILI, Toxicol. Sci., 161, 412, 10.1093/toxsci/kfx219 · DOI
- Jaeschke, 2014, Acetaminophen-induced liver injury: from animal models to humans, J. Clin. Transl. Hepatol., 2, 153
- McGill, 2012, The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation, J. Clin. Invest., 122, 1574, 10.1172/JCI59755 · DOI · Paper page
- Xie, 2015, Mitochondrial protein adducts formation and mitochondrial dysfunction during N-acetyl-m-aminophenol (AMAP)-induced hepatotoxicity in primary human hepatocytes, Toxicol. Appl. Pharmacol., 289, 213, 10.1016/j.taap.2015.09.022 · DOI
- Meyers, 1988, Acetaminophen-induced inhibition of hepatic mitochondrial respiration in mice, Toxicol. Appl. Pharmacol., 93, 378, 10.1016/0041-008X(88)90040-3 · DOI · Paper page
- Cover, 2005, Peroxynitrite-induced mitochondrial and endonuclease-mediated nuclear DNA damage in acetaminophen hepatotoxicity, J. Pharmacol. Exp. Ther., 315, 879, 10.1124/jpet.105.088898 · DOI · Paper page
- Du, 2017, Mitochondria-targeted antioxidant Mito-Tempo protects against acetaminophen hepatotoxicity, Arch. Toxicol., 91, 761, 10.1007/s00204-016-1692-0 · DOI · Paper page
- Jaeschke, 1990, Glutathione disulfide formation and oxidant stress during acetaminophen-induced hepatotoxicity in mice in vivo: the protective effect of allopurinol, J. Pharmacol. Exp. Ther., 255, 935, 10.1016/S0022-3565(25)23217-7 · DOI · Paper page
- Gunawan, 2006, c-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity, Gastroenterology, 131, 165, 10.1053/j.gastro.2006.03.045 · DOI · Paper page
- Nakagawa, 2008, Deletion of apoptosis signal-regulating kinase 1 attenuates acetaminophen-induced liver injury by inhibiting c-Jun N-terminal kinase activation, Gastroenterology, 135, 1311, 10.1053/j.gastro.2008.07.006 · DOI · Paper page
- Sharma, 2012, Critical role for mixed-lineage kinase 3 in acetaminophen-induced hepatotoxicity, Mol. Pharmacol., 82, 1001, 10.1124/mol.112.079863 · DOI
- Xie, 2015, Inhibitor of apoptosis signal-regulating kinase 1 protects against acetaminophen-induced liver injury, Toxicol. Appl. Pharmacol., 286, 1, 10.1016/j.taap.2015.03.019 · DOI
- Saito, 2010, c-Jun N-terminal kinase modulates oxidant stress and peroxynitrite formation independent of inducible nitric oxide synthase in acetaminophen hepatotoxicity, Toxicol. Appl. Pharmacol., 246, 8, 10.1016/j.taap.2010.04.015 · DOI · Paper page
- Win, 2014, JNK interaction with Sab mediates ER stress induced inhibition of mitochondrial respiration and cell death, Cell Death Dis., 5, 10.1038/cddis.2013.522 · DOI · Paper page
- Cubero, 2016, Combined activities of JNK1 and JNK2 in hepatocytes protect against toxic liver injury, Gastroenterology, 150, 968, 10.1053/j.gastro.2015.12.019 · DOI
- Du, 2015, Pathophysiological significance of c-jun N-terminal kinase in acetaminophen hepatotoxicity, Expert Opin. Drug Metab. Toxicol., 11, 1769, 10.1517/17425255.2015.1071353 · DOI
- Li, 2014, The B-Raf(V600E) inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury, Cell Death Dis., 5, 10.1038/cddis.2014.241 · DOI · Paper page
- Ramachandran, 2013, Receptor interacting protein kinase 3 is a critical early mediator of acetaminophen-induced hepatocyte necrosis in mice, Hepatology, 58, 2099, 10.1002/hep.26547 · DOI · Paper page
- Zhang, 2014, Role of receptor interacting protein (RIP)1 on apoptosis-inducing factor-mediated necroptosis during acetaminophen-evoked acute liver failure in mice, Toxicol. Lett., 225, 445, 10.1016/j.toxlet.2014.01.005 · DOI
- Dara, 2015, Receptor interacting protein kinase 1 mediates murine acetaminophen toxicity independent of the necrosome and not through necroptosis, Hepatology, 62, 1847, 10.1002/hep.27939 · DOI · Paper page
- Kon, 2004, Mitochondrial permeability transition in acetaminophen-induced necrosis and apoptosis of cultured mouse hepatocytes, Hepatology, 40, 1170, 10.1002/hep.20437 · DOI · Paper page
- Bajt, 2006, Nuclear translocation of endonuclease G and apoptosis-inducing factor during acetaminophen-induced liver cell injury, Toxicol. Sci., 94, 217, 10.1093/toxsci/kfl077 · DOI · Paper page
- Bajt, 2008, Mitochondrial Bax translocation accelerates DNA fragmentation and cell necrosis in a murine model of acetaminophen hepatotoxicity, J. Pharmacol. Exp. Ther., 324, 8, 10.1124/jpet.107.129445 · DOI · Paper page
- Gujral, 2002, Mode of cell death after acetaminophen overdose in mice: apoptosis or oncotic necrosis?, Toxicol. Sci., 67, 322, 10.1093/toxsci/67.2.322 · DOI · Paper page
- McGill, 2011, HepaRG cells: a human model to study mechanisms of acetaminophen hepatotoxicity, Hepatology, 53, 974, 10.1002/hep.24132 · DOI · Paper page
- Boxill, 1958, Comparative pharmacological and toxicological evaluation of N-acetyl-p-aminophenol, salicylamide, and acetylsalicylic acid, J. Am. Pharm. Assoc. Am. Pharm. Assoc., 47, 479, 10.1002/jps.3030470706 · doi:10.1002/jps.3030470706
- Boyd, 1966, Liver necrosis from paracetamol, Br. J. Pharmacol. Chemother., 26, 606, 10.1111/j.1476-5381.1966.tb01841.x · DOI · Paper page
- Eder, 1964, Chronic toxicity studies on phenacetin, N-Acetyl-p-Aminophenol (NAPA) and acetylsalicylic acid on cats, Acta Pharmacol. Toxicol., 21, 197, 10.1111/j.1600-0773.1964.tb01784.x · DOI
- Potter, 1974, Acetaminophen-induced hepatic necrosis V. Correlation of hepatic necrosis, covalent binding and glutathione depletion in hamsters, Pharmacology, 12, 129, 10.1159/000136531 · DOI · Paper page
- McGill, 2012, Acetaminophen-induced liver injury in rats and mice: comparison of protein adducts, mitochondrial dysfunction, and oxidative stress in the mechanism of toxicity, Toxicol. Appl. Pharmacol., 264, 387, 10.1016/j.taap.2012.08.015 · DOI · Paper page
- Davis, 1975, Hepatic glutathione depletion and impaired bromosulphthalein clearance early after paracetamol overdose in man and the rat, Clin. Sci. Mol. Med., 49, 495
- Xie, 2014, Mechanisms of acetaminophen-induced cell death in primary human hepatocytes, Toxicol. Appl. Pharmacol., 279, 266, 10.1016/j.taap.2014.05.010 · DOI · Paper page
- James, 2001, Pediatric pharmacology research unit network, NICHD. Measurement of acetaminophen-protein adducts in children and adolescents with acetaminophen overdoses, J. Clin. Pharmacol., 41, 846, 10.1177/00912700122010744 · DOI
- McGill, 2014, Serum mitochondrial biomarkers and damage-associated molecular patterns are higher in acetaminophen overdose patients with poor outcome, Hepatology, 60, 1336, 10.1002/hep.27265 · DOI · Paper page
- Bhattacharyya, 2014, Targeted liquid chromatography–mass spectrometry analysis of serum acylcarnitines in acetaminophen toxicity in children, Biomark. Med, 8, 147, 10.2217/bmm.13.150 · DOI · Paper page
- Lutkewitte, 2018, Lipin deactivation after acetaminophen overdose causes phosphatidic acid accumulation in liver and plasma in mice and humans and enhances liver regeneration, Food Chem. Toxicol., 115, 273, 10.1016/j.fct.2018.03.014 · DOI
- Marques, 2012, Chemokines and mitochondrial products activate neutrophils to amplify organ injury during mouse acute liver failure, Hepatology, 56, 1971, 10.1002/hep.25801 · DOI · Paper page
- Williams, 2014, Neutrophil activation during acetaminophen hepatotoxicity and repair in mice and humans, Toxicol. Appl. Pharmacol., 275, 122, 10.1016/j.taap.2014.01.004 · DOI · Paper page
- Ni, 2012, Activation of autophagy protects against acetaminophen-induced hepatotoxicity, Hepatology, 55, 222, 10.1002/hep.24690 · DOI · Paper page
- Ni, 2016, Removal of acetaminophen protein adducts by autophagy protects against acetaminophen-induced liver injury in mice, J. Hepatol., 65, 354, 10.1016/j.jhep.2016.04.025 · DOI · Paper page
- Du, 2015, Benzyl alcohol protects against acetaminophen hepatotoxicity by inhibiting cytochrome P450 enzymes but causes mitochondrial dysfunction and cell death at higher doses, Food Chem. Toxicol., 86, 253, 10.1016/j.fct.2015.10.016 · DOI
- Du, 2013, The gap junction inhibitor 2-aminoethoxy-diphenyl-borate protects against acetaminophen hepatotoxicity by inhibiting cytochrome P450 enzymes and c-jun N-terminal kinase activation, Toxicol. Appl. Pharmacol., 273, 484, 10.1016/j.taap.2013.09.010 · DOI
- Xie, 2013, Purinergic receptor antagonist A438079 protects against acetaminophen-induced liver injury by inhibiting P450 isoenzymes, not by inflammasome activation, Toxicol. Sci., 131, 325, 10.1093/toxsci/kfs283 · DOI
- Jaeschke, 2006, Role of caspases in acetaminophen-induced liver injury, Life Sci., 78, 1670, 10.1016/j.lfs.2005.07.003 · DOI
- Kelava, 2010, Influence of small doses of various drug vehicles on acetaminophen-induced liver injury, Can. J. Physiol. Pharmacol., 88, 960, 10.1139/Y10-065 · DOI
- Siegers, 1978, Antidotal effects of dimethyl sulphoxide against paracetamol-, bromobenzene-, and thioacetamide-induced hepatotoxicity, J. Pharm. Pharmacol., 30, 375, 10.1111/j.2042-7158.1978.tb13260.x · DOI
- Williams, 2014, Protection against acetaminophen-induced liver injury by allopurinol is dependent on aldehyde oxidase-mediated liver preconditioning, Toxicol. Appl. Pharmacol., 274, 417, 10.1016/j.taap.2013.12.003 · DOI
- Ni, 2012, Liver-specific loss of Atg5 causes persistent activation of Nrf2 and protects against acetaminophen-induced liver injury, Toxicol. Sci., 127, 438, 10.1093/toxsci/kfs133 · DOI · Paper page
- Williams, 2013, Fas receptor-deficient lpr mice are protected against acetaminophen hepatotoxicity due to higher glutathione synthesis and enhanced detoxification of oxidant stress, Food Chem. Toxicol., 58, 228, 10.1016/j.fct.2013.04.031 · DOI
- Liu, 2006, Neutrophil depletion protects against murine acetaminophen hepatotoxicity, Hepatology, 43, 1220, 10.1002/hep.21175 · DOI · Paper page
- Jaeschke, 2007, Neutrophil depletion protects against murine acetaminophen hepatotoxicity: another perspective, Hepatology, 45, 1588, 10.1002/hep.21549 · DOI
- Saito, 2010, Mechanism of protection by metallothionein against acetaminophen hepatotoxicity, Toxicol. Appl. Pharmacol., 242, 182, 10.1016/j.taap.2009.10.006 · DOI
- Harrill, 2009, Population-based discovery of toxicogenomics biomarkers for hepatotoxicity using a laboratory strain diversity panel, Toxicol. Sci., 110, 235, 10.1093/toxsci/kfp096 · DOI
- Nickel, 2015, Reversal of mitochondrial transhydrogenase causes oxidative stress in heart failure, Cell Metab., 22, 472, 10.1016/j.cmet.2015.07.008 · DOI · Paper page
- Bourdi, 2011, Mispairing C57BL/6 substrains of genetically engineered mice and wild-type controls can lead to confounding results as it did in studies of JNK2 in acetaminophen and concanavalin a liver injury, Chem. Res. Toxicol., 24, 794, 10.1021/tx200143x · DOI
- Duan, 2016, Differential susceptibility to acetaminophen-induced liver injury in sub-strains of C57BL/6 mice: 6N versus 6J, Food Chem. Toxicol., 98, 107, 10.1016/j.fct.2016.10.021 · DOI
- Yohe, 2006, Involvement of Toll-like receptor 4 in acetaminophen hepatotoxicity, Am. J. Physiol. Gastrointest. Liver Physiol., 290, 10.1152/ajpgi.00239.2005 · DOI
- Jaeschke, 2012, Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity, Liver Int., 32, 8, 10.1111/j.1478-3231.2011.02501.x · DOI · Paper page
- Woolbright, 2017, The impact of sterile inflammation in acute liver injury, J. Clin. Transl. Res., 3, 170
- Antoniades, 2012, Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans, Hepatology, 56, 735, 10.1002/hep.25657 · DOI · Paper page
- Weber, 2003, Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model, Crit. Rev. Toxicol., 33, 105, 10.1080/713611034 · DOI · Paper page
- Slater, 1966, Necrogenic action of carbon tetrachloride in the rat: a speculative mechanism based on activation, Nature, 209, 36, 10.1038/209036a0 · DOI · Paper page
- Knockaert, 2012, Carbon tetrachloride-mediated lipid peroxidation induces early mitochondrial alterations in mouse liver, Lab. Investig., 92, 396, 10.1038/labinvest.2011.193 · DOI
- Díaz Gómez, 1975, Species differences in carbon tetrachloride-induced hepatotoxicity: the role of CCl4 activation and of lipid peroxidation, Toxicol. Appl. Pharmacol., 34, 102, 10.1016/0041-008X(75)90179-9 · DOI
- Thrall, 2000, Comparative metabolism of carbon tetrachloride in rats, mice, and hamsters using gas uptake and PBPK modeling, J. Toxicol. Environ. Health A, 60, 531, 10.1080/00984100050082085 · DOI
- Teschke, 2018, Liver injury by carbon tetrachloride intoxication in 16 patients treated with forced ventilation to accelerate toxin removal via the lungs: a clinical report, Toxics, 6, 10.3390/toxics6020025 · DOI
- Castro, 1974, Prevention of carbon tetrachloride-induced necrosis by inhibitors of drug metabolism—further studies on their mechanism of action, Biochem. Pharmacol., 23, 295, 10.1016/0006-2952(74)90420-1 · DOI
- Randle, 2008, Investigation of the effect of a panel of model hepatotoxins on the Nrf2-Keap1 defence response pathway in CD-1 mice, Toxicology, 243, 249, 10.1016/j.tox.2007.10.011 · DOI
- Xu, 2008, The Nrf2 transcription factor protects from toxin-induced liver injury and fibrosis, Lab. Investig., 88, 1068, 10.1038/labinvest.2008.75 · DOI · Paper page
- McCracken, 2017, C57BL/6 substrains exhibit different responses to acute carbon tetrachloride exposure: implications for work involving transgenic mice, Gene Expr., 17, 187, 10.3727/105221617X695050 · DOI
- Tsukamoto, 2009, “Second Hit” models of alcoholic liver disease, Semin. Liver Dis., 29, 178, 10.1055/s-0029-1214373 · DOI
- Chiang, 2013, Adenosine 2A receptor antagonist prevented and reversed liver fibrosis in a mouse model of ethanol-exacerbated liver fibrosis, PLoS One, 8, 10.1371/journal.pone.0069114 · DOI
- Hall, 1991, Hepatic fibrosis and cirrhosis after chronic administration of alcohol and “low-dose” carbon tetrachloride vapor in the rat, Hepatology, 13, 815, 10.1016/0270-9139(91)90246-R · doi:10.1016/0270-9139(91)90246-r
- Kubota, 2013, A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non-alcoholic steatohepatitis in mice, Clin. Exp. Pharmacol. Physiol., 40, 422, 10.1111/1440-1681.12102 · DOI
- Hajovsky, 2012, Metabolism and toxicity of thioacetamide and thioacetamide S-oxide in rat hepatocytes, Chem. Res. Toxicol., 25, 1955, 10.1021/tx3002719 · DOI · Paper page
- Hunter, 1977, Thioacetamide-induced hepatic necrosis. I. Involvement of the mixed-function oxidase enzyme system, J. Pharmacol. Exp. Ther., 200, 439, 10.1016/S0022-3565(25)30789-5 · DOI · Paper page
- Kang, 2008, Role of CYP2E1 in thioacetamide-induced mouse hepatotoxicity, Toxicol. Appl. Pharmacol., 228, 295, 10.1016/j.taap.2007.11.010 · DOI
- Belinsky, 1985, Hepatotoxicity due to allyl alcohol in deermice depends on alcohol dehydrogenase, Hepatology, 5, 1179, 10.1002/hep.1840050619 · DOI
- Brodie, 1971, Possible mechanism of liver necrosis caused by aromatic organic compounds, Proc. Natl. Acad. Sci. U. S. A., 68, 160, 10.1073/pnas.68.1.160 · DOI · Paper page
- McGill, 2015, The role of the c-Jun N-terminal kinases 1/2 and receptor-interacting protein kinase 3 in furosemide-induced liver injury, Xenobiotica, 45, 442, 10.3109/00498254.2014.986250 · DOI
- Williams, 2007, The metabolism and toxicity of furosemide in the Wistar rat and CD-1 mouse: a chemical and biochemical definition of the toxicophore, J. Pharmacol. Exp. Ther., 322, 1208, 10.1124/jpet.107.125302 · DOI
- Jaeschke, 1987, The role of acrolein in allyl alcohol-induced lipid peroxidation and liver cell damage in mice, Biochem. Pharmacol., 36, 51, 10.1016/0006-2952(87)90381-9 · DOI
- Leist, 1995, Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models, Am. J. Pathol., 146, 1220
- Bechmann, 2008, Apoptosis versus necrosis rate as a predictor in acute liver failure following acetaminophen intoxication compared with acute-on-chronic liver failure, Liver Int., 28, 713, 10.1111/j.1478-3231.2007.01566.x · DOI
- Jaeschke, 2012, Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity, Drug Metab. Rev., 44, 88, 10.3109/03602532.2011.602688 · DOI · Paper page
- Ramachandran, 2018, Mitochondrial dysfunction as a mechanism of drug-induced hepatotoxicity: current understanding and future perspectives, J. Clin. Transl. Res.
- Leach, 1941, Sulfonamide drugs as protective agents against carbon tetrachloride poisoning, Exp. Biol. Med. (Maywood), 48, 361, 10.3181/00379727-48-13322P · DOI
- Roth, 1997, Is exposure to bacterial endotoxin a determinant of susceptibility to intoxication from xenobiotic agents?, Toxicol. Appl. Pharmacol., 147, 300, 10.1006/taap.1997.8301 · DOI · Paper page
- Dickes, 1957, Serial liver-function and blood studies in patients receiving chlorpromazine, N. Engl. J. Med., 256, 1, 10.1056/NEJM195701032560101 · doi:10.1056/nejm195701032560101
- Buchweitz, 2002, Underlying endotoxemia augments toxic responses to chlorpromazine: is there a relationship to drug idiosyncrasy?, J. Pharmacol. Exp. Ther., 300, 460, 10.1124/jpet.300.2.460 · DOI
- Deng, 2006, Modest inflammation enhances diclofenac hepatotoxicity in rats: role of neutrophils and bacterial translocation, J. Pharmacol. Exp. Ther., 319, 1191, 10.1124/jpet.106.110247 · DOI
- Dugan, 2010, A mouse model of severe halothane hepatitis based on human risk factors, J. Pharmacol. Exp. Ther., 333, 364, 10.1124/jpet.109.164541 · DOI
- Lu, 2012, Amiodarone exposure during modest inflammation induces idiosyncrasy-like liver injury in rats: role of tumor necrosis factor-alpha, Toxicol. Sci., 125, 126, 10.1093/toxsci/kfr266 · DOI
- Luyendyk, 2003, Ranitidine treatment during a modest inflammatory response precipitates idiosyncrasy-like liver injury in rats, J. Pharmacol. Exp. Ther., 307, 9, 10.1124/jpet.103.054288 · DOI
- Shaw, 2007, Lipopolysaccharide and trovafloxacin coexposure in mice causes idiosyncrasy-like liver injury dependent on tumor necrosis factor-alpha, Toxicol. Sci., 100, 259, 10.1093/toxsci/kfm218 · DOI · Paper page
- Uetrecht, 2013, Idiosyncratic adverse drug reactions: current concepts, Pharmacol. Rev., 65, 779, 10.1124/pr.113.007450 · DOI · Paper page
- Mosedale, 2017, Drug-induced liver injury: advances in mechanistic understanding that will inform risk management, Clin. Pharmacol. Ther., 101, 469, 10.1002/cpt.564 · DOI · Paper page
- Maddox, 2010, Bacterial- and viral-induced inflammation increases sensitivity to acetaminophen hepatotoxicity, J. Toxicol. Environ. Health A, 73, 58, 10.1080/15287390903249057 · DOI
- Williams, 2010, Acetaminophen-induced hepatic neutrophil accumulation and inflammatory liver injury in CD18-deficient mice, Liver Int., 30, 1280, 10.1111/j.1478-3231.2010.02284.x · DOI
- Pastor Rojo, 2007, Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease, Inflamm. Bowel Dis., 13, 269, 10.1002/ibd.20019 · DOI · Paper page
- Metushi, 2015, Development of a novel mouse model of amodiaquine-induced liver injury with a delayed onset, J. Immunotoxicol., 12, 247, 10.3109/1547691X.2014.934977 · DOI
- Metushi, 2015, Treatment of PD-1 −/− mice with amodiaquine and anti-CTLA4 leads to liver injury similar to idiosyncratic liver injury in patients, Hepatology, 61, 1332, 10.1002/hep.27549 · DOI · Paper page
- Ong, 2007, Troglitazone-induced hepatic necrosis in an animal model of silent genetic mitochondrial abnormalities, Toxicol. Sci., 97, 205, 10.1093/toxsci/kfl180 · DOI · Paper page
- Fujimoto, 2009, Sensitivity of liver injury in heterozygous Sod2 knockout mice treated with troglitazone or acetaminophen, Toxicol. Pathol., 37, 193, 10.1177/0192623308329282 · DOI
- Hsiao, 2010, Trovafloxacin, a fluoroquinolone antibiotic with hepatotoxic potential, causes mitochondrial peroxynitrite stress in a mouse model of underlying mitochondrial dysfunction, Chem. Biol. Interact., 188, 204, 10.1016/j.cbi.2010.07.017 · DOI
- Kashimshetty, 2009, Underlying mitochondrial dysfunction triggers flutamide-induced oxidative liver injury in a mouse model of idiosyncratic drug toxicity, Toxicol. Appl. Pharmacol., 238, 150, 10.1016/j.taap.2009.05.007 · DOI
- Ong, 2006, Nimesulide-induced hepatic mitochondrial injury in heterozygous Sod2+/− mice, Free Radic. Biol. Med., 40, 420, 10.1016/j.freeradbiomed.2005.08.038 · DOI
- Lucena, 2010, Mitochondrial superoxide dismutase and glutathione peroxidase in idiosyncratic drug-induced liver injury, Hepatology, 52, 303, 10.1002/hep.23668 · DOI
- Nicoletti, 2017, Gastroenterology, 152, 1078, 10.1053/j.gastro.2016.12.016 · DOI · Paper page
- McGill, 2018, Biomarkers of drug-induced liver injury: progress and utility in research, medicine, and regulation, Expert. Rev. Mol. Diagn., 10.1080/14737159.2018.1508998 · DOI
- Turpeinen, 2007, Predictive value of animal models for human cytochrome P450 (CYP)-mediated metabolism: a comparative study in vitro, Xenobiotica, 37, 1367, 10.1080/00498250701658312 · DOI
- Trepanier, 1997, Cytosolic arylamine N-acetyltransferase (NAT) deficiency in the dog and other canids due to an absence of NAT genes, Biochem. Pharmacol., 54, 73, 10.1016/S0006-2952(97)00140-8 · DOI
- Trepanier, 2004, Idiosyncratic toxicity associated with potentiated sulfonamides in the dog, J. Vet. Pharmacol. Ther., 27, 129, 10.1111/j.1365-2885.2004.00576.x · DOI
- Court, 2000, Molecular genetic basis for deficient acetaminophen glucuronidation by cats: UGT1A6 is a pseudogene, and evidence for reduced diversity of expressed hepatic UGT1A isoforms, Pharmacogenetics, 10, 355, 10.1097/00008571-200006000-00009 · DOI · Paper page
Cited by
Role of prostaglandin E2 in tissue repair and regeneration
Cheng, H., Huang, H., Guo, Z., Chang, Y., & Li, Z. (2021) · Theranostics · doi:10.7150/thno.63396 · Cited by 315
Drug induced liver injury: an update
Garcia-Cortes, M., Robles-Diaz, M., Stephens, C., Ortega-Alonso, A., Lucena, M. I., & Andrade, R. J. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02885-1 · Cited by 286
Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry
Stephens, C., Robles-Diaz, M., Medina-Caliz, I., Garcia-Cortes, M., Ortega-Alonso, A., Sanabria-Cabrera, J., Gonzalez-Jimenez, A., Alvarez-Alvarez, I., Slim, M., Jimenez-Perez, M., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.01.029 · Cited by 148
Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics
Ma, X., Huang, T., Chen, X., Li, Q., Liao, M., Fu, L., Huang, J., Yuan, K., Wang, Z., & Zeng, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02104-8 · Cited by 133
An update on animal models of liver fibrosis
Wu, S., Wang, X., Xing, W., Li, F., Liang, M., Li, K., He, Y., & Wang, J. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1160053 · Cited by 71
Metadata
- Authors
- McGill, M. R., & Jaeschke, H.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Published
- 2019-05
- Volume
- 1865
- Issue
- 5
- Pages
- 1031-1039
- ISSN
- 0925-4439
- PMC
- PMC6478394
- Cited by
- 185
- References
- 6
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 367 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Funders
- University of Arkansas for Medical Sciences
- National Institutes of Health (R01 DK102142, P20 GM103549, P30 GM118247)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.